Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats (Q43662467)

25 November 2017

Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats (English)

1 reference

25 November 2017

1 reference

3

Popik P

1 reference

25 November 2017

2

Danysz W

1 reference

25 November 2017

Kozela E

1

1 reference

PubMed ID

11438302

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Journal of Pharmacology

25 November 2017

1 reference

25 November 2017

423

1 reference

25 November 2017

1

1 reference

25 November 2017

17-26

1 reference

Potentiation of morphine-induced antinociception in acute spinal rats by the NMDA antagonist dextrorphan

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Treatment of Impaired Cerebral Function in Psychogeriatric Patients with Memantine - Results of a Phase II Double-Blind Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

New hot plate tests to quantify antinociceptive and narcotic antagonist activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Antagonist properties of eliprodil and other NMDA receptor antagonists at rat NR1A/NR2A and NR1A/NR2B receptors expressed in Xenopus oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Low-dose subcutaneous ketamine infusion and morphine tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Prolongation of morphine analgesia by competitive NMDA receptor antagonist D-CPPene (SDZ EAA 494) in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Evidence for opiate-activated NMDA processes masking opiate analgesia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Dextromethorphan and dextrorphan in rats: common antitussives--different behavioural profiles.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

N-methyl-D-aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

The NMDA receptor: central role in pain inhibition in rat periaqueductal gray

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

The specific N-methyl-D-aspartate (NMDA) receptor antagonist MK-801 blocks U-50,488, but not morphine antinociception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Oral administration of dextromethorphan prevents the development of morphine tolerance and dependence in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Glutamate in CNS disorders as a target for drug development: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Amino-alkyl-cyclohexanes are novel uncompetitive NMDA receptor antagonists with strong voltage-dependency and fast blocking kinetics: in vitro and in vivo characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Genetic differences in the antinociceptive effect of morphine and its potentiation by dextromethorphan in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Analgesia produced by microinjection ofl-glutamate into the rostral ventromedial bulbar nuclei of the rat and its inhibition by intrathecal α-adrenergic blocking agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Excitatory amino acid antagonists in the rostral ventromedial medulla inhibit mesencephalic morphine analgesia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Dextromethorphan and neuromodulation: old drug coughs up new activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

[3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

Acute tolerance in morphine analgesia: continuous infusion and single injection in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2901084-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)01084-6

1 reference

25 November 2017

1 reference

PubMed ID

11438302